723 related articles for article (PubMed ID: 25993023)
41. [Cytokine profile changes in children with juvenile idiopathic arthritis-associated uveitis].
Drozdova EA; Yadykina EV; Mezentseva EA; Nikushkina KV
Vestn Oftalmol; 2017; 133(1):27-31. PubMed ID: 28291196
[TBL] [Abstract][Full Text] [Related]
42. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
43. Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes.
Su Y; Yang YH; Chiang BL
Clin Rheumatol; 2017 Sep; 36(9):1997-2004. PubMed ID: 28540607
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
45. A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.
Leinonen S
Acta Ophthalmol; 2023 Jun; 101(4):465-468. PubMed ID: 36458735
[TBL] [Abstract][Full Text] [Related]
46. The Effect of Leflunomide as Adjunctive Therapy With a TNF Inhibitor in Pediatric Patients With Uveitis.
Garg N; Cohen E; Tsui E; LaMattina KC
J Pediatr Ophthalmol Strabismus; 2023; 60(6):417-420. PubMed ID: 36546781
[TBL] [Abstract][Full Text] [Related]
47. Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Lovell DJ; Johnson AL; Huang B; Gottlieb BS; Morris PW; Kimura Y; Onel K; Li SC; Grom AA; Taylor J; Brunner HI; Huggins JL; Nocton JJ; Haines KA; Edelheit BS; Shishov M; Jung LK; Williams CB; Tesher MS; Costanzo DM; Zemel LS; Dare JA; Passo MH; Ede KC; Olson JC; Cassidy EA; Griffin TA; Wagner-Weiner L; Weiss JE; Vogler LB; Rouster-Stevens KA; Beukelman T; Cron RQ; Kietz D; Schikler K; Schmidt KM; Mehta J; Wahezi DM; Ting TV; Verbsky JW; Eberhard BA; Spalding S; Chen C; Giannini EH
Arthritis Rheumatol; 2018 Sep; 70(9):1508-1518. PubMed ID: 29604189
[TBL] [Abstract][Full Text] [Related]
48. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
[TBL] [Abstract][Full Text] [Related]
49. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
50. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
Aletaha D; Stamm T; Kapral T; Eberl G; Grisar J; Machold KP; Smolen JS
Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
[TBL] [Abstract][Full Text] [Related]
51. Ocular threat in juvenile idiopathic arthritis.
Marvillet I; Terrada C; Quartier P; Quoc EB; Bodaghi B; Prieur AM
Joint Bone Spine; 2009 Jul; 76(4):383-8. PubMed ID: 19524473
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication.
Heiligenhaus A; Mingels A; Heinz C; Ganser G
Eur J Ophthalmol; 2007; 17(5):743-8. PubMed ID: 17932849
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience.
Baszis K; Garbutt J; Toib D; Mao J; King A; White A; French A
Arthritis Rheum; 2011 Oct; 63(10):3163-8. PubMed ID: 21702011
[TBL] [Abstract][Full Text] [Related]
54. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
Singer O; Gibofsky A
Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
[TBL] [Abstract][Full Text] [Related]
55. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic DS; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ;
J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
[TBL] [Abstract][Full Text] [Related]
56. Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study.
Ede K; Shishov M; Wershba E; Goswami N; Gorry S; Joseph M; Mirea L; O'Neil J
Pediatr Rheumatol Online J; 2024 Jan; 22(1):22. PubMed ID: 38279120
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study.
Guignard S; Gossec L; Salliot C; Ruyssen-Witrand A; Luc M; Duclos M; Dougados M
Ann Rheum Dis; 2006 Dec; 65(12):1631-4. PubMed ID: 16901960
[TBL] [Abstract][Full Text] [Related]
58. Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Magallares B; Hernández MV; Reina D; Corominas H; Sanmartí R; de la Serna AR; Llobet JM; Nolla JM
PLoS One; 2015; 10(4):e0123392. PubMed ID: 25830224
[TBL] [Abstract][Full Text] [Related]
59. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Tappeiner C; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Eye (Lond); 2009 May; 23(5):1192-8. PubMed ID: 18551142
[TBL] [Abstract][Full Text] [Related]
60. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
